Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer's disease in Han Chinese individuals

Neurobiology of Aging

Volumn 35, Issue 4, 2014, Pages 937.e1-937.e3

  Yu, Jin Tai ^a,b,c   Jiang, Teng ^a   Wang, Ying Li ^b   Wang, Hui Fu ^b   Zhang, Wei ^b   Hu, Nan ^b   Tan, Lin ^b   Sun, Lei ^b   Tan, Meng Shan ^c   Zhu, Xi Chen ^a   Tan, Lan ^a,b,c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Alzheimer's disease; Association; Genetic; Mutation; TREM2

Indexed keywords

AGE DISTRIBUTION; ALZHEIMER DISEASE; ARTICLE; BONE MARROW CELL; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; TREM2 GENE;

ALZHEIMER'S DISEASE; ASSOCIATION; GENETIC; MUTATION; TREM2;

ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; EXONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE GLYCOPROTEINS; MUTATION; RECEPTORS, IMMUNOLOGIC; RISK;

EID: 85058205511     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.10.075     Document Type: Article

References (14)

1. Benitez B.A., Cooper B., Pastor P., Jin S.C., Lorenzo E., Cervantes S., Cruchaga C. TREM2 is associated with the risk of Alzheimer's disease in Spanish population. Neurobiol. Aging 2013, 34:1711.e15-1711.e17. 10.1016/j.neurobiolaging.2012.12.018.
2. Duan J., Wainwright M.S., Comeron J.M., Saitou N., Sanders A.R., Gelernter J., Gejman P.V. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 2003, 12:205-216.
3. Fisher Y., Nemirovsky A., Baron R., Monsonego A. Tcells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer's disease. PloS one 2010, 5:e10830. 10.1371/journal.pone.0010830.
4. Frank S., Burbach G.J., Bonin M., Walter M., Streit W., Bechmann I., Deller T. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 2008, 56:1438-1447. 10.1002/glia.20710.
5. Giraldo M., Lopera F., Siniard A.L., Corneveaux J.J., Schrauwen I., Carvajal J., Munoz C., Ramirez-Restrepo M., Gaiteri C., Myers A.J., Caselli R.J., Kosik K.S., Reiman E.M., Huentelman M.J. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Neurobiol. Aging 2013, 34:2077.e11-2077.e18. 10.1016/j.neurobiolaging.2013.02.016.
6. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S., Younkin S., Hazrati L., Collinge J., Pocock J., Lashley T., Williams J., Lambert J.C., Amouyel P., Goate A., Rademakers R., Morgan K., Powell J., St George-Hyslop P., Singleton A., Hardy J. TREM2 variants in Alzheimer's disease. N.Engl. J. Med. 2013, 368:117-127. 10.1056/NEJMoa1211851.
7. Hu N., Tan M.S., Yu J.T., Sun L., Tan L., Wang Y.L., Jiang T. Increased expression of TREM2 in Peripheral blood of Alzheimer's disease patients. J.Alzheimer's Dis 2013, 10.3233/JAD-130854.
8. Jiang T., Yu J.T., Zhu X.C., Tan L. TREM2 in Alzheimer's disease. Mol. Neurobiol. 2013, 48:180-185. 10.1007/s12035-013-8424-8.
9. Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J., Rujescu D., Hampel H., Giegling I., Andreassen O.A., Engedal K., Ulstein I., Djurovic S., Ibrahim-Verbaas C., Hofman A., Ikram M.A., van Duijn C.M., Thorsteinsdottir U., Kong A., Stefansson K. Variant of TREM2 associated with the risk of Alzheimer's disease. N.Engl. J. Med. 2013, 368:107-116. 10.1056/NEJMoa1211103.
10. Melchior B., Garcia A.E., Hsiung B.K., Lo K.M., Doose J.M., Thrash J.C., Stalder A.K., Staufenbiel M., Neumann H., Carson M.J. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease. ASN Neuro 2010, 2:e00037. 10.1042/AN20100010.
11. Pottier C., Wallon D., Rousseau S., Rovelet-Lecrux A., Richard A.C., Rollin-Sillaire A., Frebourg T., Campion D., Hannequin D. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease. J.Alzheimer's Dis. 2013, 35:45-49. 10.3233/JAD-122311.
12. Takahashi K., Prinz M., Stagi M., Chechneva O., Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med. 2007, 4:e124. 10.1371/journal.pmed.0040124.
13. Takahashi K., Rochford C.D., Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J.Exp. Med. 2005, 201:647-657. 10.1084/jem.20041611.
14. Yu J.T., Ma X.Y., Wang Y.L., Sun L., Tan L., Hu N. Genetic variation in Clusterin gene and Alzheimer's disease risk in Han Chinese. Neurobiol. Aging 2013, 34:1921.e17-1921.e23. 10.1016/j.neurobiolaging.2013.01.010.